Scientists hail promise of first effective Ebola treatments in Congo trial

Although we are headquartered in Washington D.C. USA, our reporters and editors are working around the globe to cover what you care about. We invite you to donate to our fundraiser to help us keep our quality news free and available to all.  

By Kate Kelland

LONDON (Reuters) – Scientists are a step closer to finding the first effective treatments for the deadly Ebola haemorrhagic fever after two potential drugs showed encouraging survival results in a clinical trial in Congo.A health worker fills a syringe with Ebola vaccine before injecting it to a patient, in Goma, Democratic Republic of Congo, August 5, 2019. REUTERS/Baz Ratner/File Pho

Two experimental drugs – Regeneron’s REGN-EB3 and a monoclonal antibody called mAb114 – were both developed using antibodies harvested from survivors of Ebola infection.

[read_more id="2" more="Read full article" less="Read less"]

They showed “clearly better” results in patients in a trial of four potential treatments being conducted during the world’s second largest Ebola outbreak in history, now entering its second year in Democratic Republic of Congo (DRC).

The drugs improved survival rates from the disease more than two other treatments being tested – ZMapp, made by Mapp Biopharmaceutical, and Remdesivir, made by Gilead Sciences – and those products will be now dropped, said Anthony Fauci, one of the researchers co-leading the trial.

Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, told reporters in a telebriefing the results were “very good news” for the fight against Ebola.

“What this means is that we do now have what look like (two) treatments for a disease for which not long ago we really had no approach at all,” he said.

Ebola has been spreading in eastern Congo since August 2018 in an outbreak that has now become the second largest, killing at least 1,800 people. Efforts to control it have been hampered by militia violence and some local resistance to outside help.

A vast Ebola outbreak in West Africa become the world’s largest ever when it spread through Guinea, Liberia and Sierra Leone from 2013 to 2016 and killed more than 11,300 people.

ADVERTISEMENT

The Congo treatment trial, which began in November last year, is being carried out by an international research group coordinated by the World Health Organization (WHO).

Mike Ryan, head of the WHO’s emergencies program, said the trial’s positive findings were encouraging but would not be enough on their own to bring the epidemic to an end.

“The news today is fantastic. It gives us a new tool in our toolbox against Ebola, but it will not in itself stop Ebola,” he told reporters.

Jeremy Farrar, director of the Wellcome Trust global health charity, also hailed the success of the trial’s findings, saying they would “undoubtedly save lives.”

“The more we learn about these two treatments,…the closer we can get to turning Ebola from a terrifying disease to one that is preventable and treatable,” he added in a statement.

ADVERTISEMENT

“We won’t ever get rid of Ebola but we should be able to stop these outbreaks from turning into major national and regional epidemics.”

Some 681 patients at four separate treatment centers in Congo have already been enrolled in the Congo treatment clinical trial, Fauci said. The study aims to enroll a total of 725.

The decision to drop two of the trial drugs was based on data from almost 500 patients, he said, which showed that those who got REGN-EB3 or mAb114 “had a greater chance of survival compared to those participants in the other two arms.”

[/read_more]

Today News Africa
Today News Africahttps://todaynewsafrica.com
TODAY NEWS AFRICA is registered and headquartered in Washington, District of Columbia, United States of America. Our publication is widely read, respected and influential. By providing daily answers to questions our readers have about the people, the businesses and the continent of Africa, we are reaching a diverse and wide audience from around the world. Our readers, many of them world leaders, trust us because we are independent and truthful. Our advertisers understand the difference between news, views and ads. Contact us: contactus@todaynewsafrica.com

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Trending Now

DR Congo rebel commander wanted for multiple crimes still a free man

Congolese authorities have not arrested a rebel commander wanted for multiple crimes under a June 2019 warrant even as his forces have...

Trump says Sudan to be removed from terrorism list if it pays $335 million in compensation

President Donald Trump on Monday said Sudan will be removed from the U.S. list of state sponsors of terrorism once it...

Anxiety in Africa as Johnson & Johnson conceals critical details about COVID-19 vaccine illness

Anxiety continued to mount across Sub-Saharan Africa on Monday over COVID-19 vaccine trials by Johnsons & Johnson, as the company continued...

Rights group urges AU to denounce crackdown on Cameroon’s opposition

Human Rights Watch on Monday urged the African Union (AU), the African Commission on Human and Peoples’ Rights (ACHPR), the Economic...

Mass prison break: Thugs disguised as protesters free over 200 inmates in Nigeria

Thugs disguised as protesters have freed over 200 inmates in Nigeria.The criminals disguised as EndSARS protesters freed...

MOST POPULAR

Damning report finds detainees in Iran were sexually abused and given electric shocks in gruesome post-protest crackdown

Iran’s police, intelligence and security forces, and prison officials have committed, with the complicity of judges and prosecutors, a catalogue of...

Africa shocked U.S. under Trump has worst coronavirus response in the world

President Donald Trump has "failed in his basic duty to protect Americans", world's renowned journalist Bob Woodward told Fox News Sunday...

IMF’s Georgieva says second round of support coming to Africa but Oxfam argues debt cancelation the only way out of COVID-19 turmoil

The Managing Director of the International Monetary Fund (IMF) Ms. Kristalina Georgieva said on Wednesday that the Washington DC-based institution is...

Johnson & Johnson vaccine trial taking place in South Africa halted by participant’s illness

Johnson & Johnson confirmed on Monday that it had paused its COVID-19 vaccine study because one of its participants was taken...

EXCLUSIVE: IMF economist details how COVID-19 economic turmoil in Asia will affect Sub-Saharan Africa

The COVID-19 pandemic is battering economies in Asia with a contraction expected for the first time in many decades. The economic...

DR Congo rebel commander wanted for multiple crimes still a free man

Congolese authorities have not arrested a rebel commander wanted for multiple crimes under a June 2019 warrant even as his forces have continued to carry out summary killings, rapes and sexual slavery, extortion, and forced recruitment of children, Human Rights Watch said on Monday.Congolese judicial authorities on June 7, 2019 issued the warrant for the militia leader, Guidon Shimiray Mwissa (known as Guidon),...

[/read_more]

[read_more id="2" more="Read full article" less="Read less"]

Share
WhatsApp
Reddit
Tweet
Share